Abiopharma

Yates Bryant J 🟡 adjusted position in 4.8K shares of NATURES SUNSHINE PRODUCTS INC (NATR) at $25.91 Transaction Date: May 05, 2026 | Filing ID: 032337

(30% Negative) ROCKET COMPANIES, INC. (RKT) Reports Q2 2026 Financial Results

Director Kelderman Kim 🟡 adjusted position in 716.1K shares (17 derivative) of BIO-TECHNE Corp (TECH) at $120.46 ($39.4M) Transaction Date: May 05, 2026 | Filing ID: 000088

📋 BRYAN GIRAUDO (Director) plans to sell 36K shares of PROTAGONIST THERAPEUTICS, INC. (at $100.14 each, total $3.6M) Filed: May 07, 2026 | ID: 004220

New Form SCHEDULE 13G/A - StandardAero, Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001140361-26-019634 <b>Size:</b> 11 KB

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces New Board Appointment

Director KEATING NEAL J. 🟢 acquired 7.5K shares (2 derivative) of HUBBELL INC (HUBB) Transaction Date: May 05, 2026 | Filing ID: 032334

(10% Negative) DXP ENTERPRISES INC (DXPE) Reports Q2 2026 Financial Results

(75% Positive) SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) Announces New Board Appointment

(99% Neutral) NATURES SUNSHINE PRODUCTS INC (NATR) Reports Q2 2026 Financial Results